Where does Senex Biotechnology, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Senex Biotechnology, Inc. ranks #37,407 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Senex Biotechnology, Inc. hold?

Senex Biotechnology, Inc. holds 7 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Senex Biotechnology, Inc.'s Innovation Score?

Senex Biotechnology, Inc. has an Innovation Score of 24.9 out of 100 (16th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Senex Biotechnology, Inc. focus on?

Senex Biotechnology, Inc.'s top technology area is C07D (Heterocyclic Compounds) with 6 patents. Grants appear in 5 CPC subclasses total.

Is Senex Biotechnology, Inc.'s patent grant rate increasing or decreasing?

Senex Biotechnology, Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Senex Biotechnology, Inc.'s patents?

Senex Biotechnology, Inc.'s patents average 12.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Senex Biotechnology, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Senex Biotechnology, Inc.

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Senex ranks #37,407 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#37,407
of 49,997 US assignees by volume: 16th percentile
by Innovation Score (24.9/100): 12.7
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R37407 · US Corporation #37,407 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #37,407/49,997
PHOTO-FINISH Sedation Systems
CPC-NARROW C07D · 5 areas
INNOV-THIN 24.9/100
CLAIMS-RICH 12.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sedation Systems, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Container Graphics · near

25
Senex Biotechnology · this assignee

25
Hana Micron · near

25
Magnum Energy… · near

25
Smiss Technology · near

25
3D Lighting… · lowest

7

What this shows Senex's Innovation Score is 24.9/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Senex's grants concentrate

Senex Biotechnology, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 85.7% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2020. By volume, Senex sits between Sedation Systems, LLC and Serenity Data Security, LLC.

Senex's three-year grant acceleration

Senex Biotechnology, Inc. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sedation Systems

7
Segars California…

7
Semiwise

7
Semprus Bioscienc…

7
Sensable

7
Sensogram

7
Sensor Platforms

7
Serenity Data Sec…

7
Senex Biotechnolo… ◀

7

What this shows Senex holds 7 patents at rank #37,575, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Senex

By rank, the assignees closest to #37,575 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Senex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Senex, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (25 here).

Container Graphics Corporation 25 Hana Micron Inc. 25 Magnum Energy Solutions, LLC 25 Smiss Technology Co., Ltd. 25

Senex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Senex Biotechnology, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	28.6%
2020	1	14.3%
2021	2	28.6%
2023	1	14.3%
2025partial year	1	14.3%

Which technologies does Senex Biotechnology, Inc. patent most?

C07D - Heterocyclic Compounds 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#37,407

of 49,997 tracked assignees

Innovation Score

24.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Senex Biotechnology, Inc.'s patent record in context - here's where to go next.

Senex Biotechnology, Inc.'s lead technology class is C07D (Heterocyclic Compounds), 85.7% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #37,407 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Senex Biotechnology, Inc. against Sedation Systems, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.